Endometrioid Endometrial RNA Index Predicts Recurrence in Stage I Patients

CONCLUSIONS: Tumors with high-risk genetic features may require additional treatment or closer monitoring and are not readily identified using traditional clinicopathologic and molecular features. EERI performs with high sensitivity and modest specificity, which may benefit from further optimization and validation in larger independent cohorts.PMID:38669067 | DOI:10.1158/1078-0432.CCR-23-3158

Source: Cancer Control - April 26, 2024 Category: Cancer & Oncology Authors: Corrine A Nief Phoebe M Hammer Aihui Wang Vivek Charu Amina Tanweer Babak Litkouhi Elizabeth Kidd Andrew J Gentles Brooke E Howitt Source Type: research